• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Implantable Bioreactor for Kidney Cells

      Implantable Bioreactor for Kidney Cells

      Etched Nanopillars Kill Bacteria, Fungi on Titanium Implants

      Etched Nanopillars Kill Bacteria, Fungi on Titanium Implants

      Cells Release Insulin in Response to Music

      Cells Release Insulin in Response to Music

    • Radiology
      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Imaging Technique Reveals Living Brain Tissue in its Complexity

      Imaging Technique Reveals Living Brain Tissue in its Complexity

      Wearable Ultrasound for Deep Tissue Monitoring

      Wearable Ultrasound for Deep Tissue Monitoring

    • Cardiology
      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      3D Printed Heart Muscle Beats

      3D Printed Heart Muscle Beats

      Wireless Patch Monitors, Paces Heart and then Biodegrades

      Wireless Patch Monitors, Paces Heart and then Biodegrades

      Photonic Radar Monitors Breathing from a Distance

      Photonic Radar Monitors Breathing from a Distance

    • Surgery
      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Droplet Battery Harnesses Ionic Gradients for Bioelectronic Implants

      Droplet Battery Harnesses Ionic Gradients for Bioelectronic Implants

      Implantable Bioreactor for Kidney Cells

      Implantable Bioreactor for Kidney Cells

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

    • Nanomedicine
      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

    • Military Medicine
      Wearable Can Take Multiple Sweat Samples

      Wearable Can Take Multiple Sweat Samples

      Wound Dressing Detects Infection, Changes Color

      Wound Dressing Detects Infection, Changes Color

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

    • Rehab
      Optical Strain Sensors for Rehab

      Optical Strain Sensors for Rehab

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Brain Computer Interface Decodes Speech and Facial Expressions

      Brain Computer Interface Decodes Speech and Facial Expressions

      Semi-Automated Manufacture of E-Skin Sensors

      Semi-Automated Manufacture of E-Skin Sensors

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Injectable Hydrogel for Transcatheter Intravascular Embolization: Interview with Dr. Rahmi Oklu, Founder of Obsidio

September 6th, 2019 Conn Hastings Cardiac Surgery, Exclusive, Neurosurgery, Oncology, Surgery, Vascular Surgery

Obsidio Inc., a medical device company based in Columbia, South Carolina, has developed an embolic hydrogel (called a gel embolic material: GEM) designed to be delivered minimally invasively through a clinical catheter for blood vessel occlusion. Applications include controlling blood flow in vascular injuries and aneurysms, reducing tumor blood supply, and preventing abnormal blood flow between arteries and veins, such as arteriovenous malformations.

Currently, the gold standard treatment in terms of transcatheter embolization involves delivering multiple metal coils into a blood vessel, which works by promoting coagulation so that the clot around the coil stops the flow of blood. However, this approach has numerous limitations, as it is not always suitable for patients with impaired coagulation, and can sometimes fail, resulting in rebleeding.

To address this, Obsidio has developed a hydrogel material that can occlude a target vessel and which does not rely on a patient’s own coagulation ability. The material can be delivered using a catheter, and demonstrates shear thinning properties, whereby it acts as a semisolid when subjected to shear stress. This allows it to flow through a catheter during delivery but it forms a soft solid once in the blood vessel, allowing for minimally invasive embolization.

Through its substantial cohesive properties, the material is not easily dislodged and does not break up in the vessel. In fact, it fills the targeted vessel, forming a “cast” of the vessel interior to immediately stop blood flow.

Medgadget had the opportunity to ask Dr. Rahmi Oklu, Founder and Chief Medical Officer of Obsidio some questions about the technology.

Conn Hastings, Medgadget: Please give us an overview of the indications for transcatheter intravascular embolization.

Dr. Oklu, Obsidio: Our goal is to disrupt the coil embolization industry. Wherever you would use a coil, GEM can be used; for example, treatment of saccular aneurysms, gastrointestinal bleeding, trauma bleeding and gonadal vein embolization in pelvic congestion syndrome or in varicocele. We are also branching out to indications that would include embolization of vascular malformations, tumor embolization, prostate artery embolization for benign prostatic hyperplasia (BPH), and varicose vein embolization. Just to illustrate the ease of use of GEM, in an office setting, in minutes you can inject GEM under ultrasound guidance to the great saphenous vein to treat varicose veins.

Medgadget: What are the limitations of current treatment approaches?

Dr. Oklu: There are numerous limitations; I’m not sure where to begin! Coils come in all sorts of lengths, diameters and shapes; some are pushable, retractable, and require special catheters and individual coil releasing devices. If you look in an angiography room, shelf after shelf is filled with costly coils and catheters. This increases the cost burden for the hospital, for the patient, and the healthcare system. These coils also create an artifact when they are imaged; so you go through all this trouble, spend many thousands of dollars on coils and spend several hours doing the procedure exposing yourself and the patient to radiation and at the end you can’t even use an ultrasound, CT or MRI to see whether coiling worked. Doctors want to know if the coils were able to stop the bleeding by imaging. Often we look for clinical signs instead; did the blood pressure normalize, or is the heart rate back to normal, does the patient require blood transfusions? This is frustrating for the physician and a disservice to our patients. The most critical limitation of current technology is that they are ineffective in coagulopathic patients. This is, in fact, the motivation for developing GEM; a patient that I embolized passed away because the coils were not effective in stopping the bleeding. This patient was the inspiration to push us to come up with a better alternative to coil embolization. Coils today rely on the body’s ability to form a clot around the coil to stop bleeding. Another significant limitation is the time it takes to deploy a coil. Some cases may require dozens of coils; large pseudoaneurysms, portal vein embolization cases, bowel or stomach varix embolization, gonadal vein embolization. These take time to deploy, increase costs and at the end may not work.

Medgadget: How does the hydrogel embolic agent developed by Obsidio circumvent these limitations?

Dr. Oklu: Every time I do an embolization procedure, I wish that I could use GEM. Recently, I had to rush to the hospital to treat a patient with a ruptured aneurysm; the patient was vomiting up blood while on a massive transfusion protocol. I placed over 580 cm of fibered coil as fast as I could in an hour, and at the end the blood continued to go through the coils. I stopped the procedure because I just could not place any more coils, not knowing whether we helped the patient or not. With GEM, however, you would simply connect to the catheter, any catheter, and simply inject the gel. We would have finished in under a minute knowing at the end that the bleeding had stopped. The gel would simply fill the aneurysm space to create an impenetrable cast. GEM would replace the massive coil/catheter inventory in the angiography suite reducing costs to the hospital. GEM would also reduce procedure time, reduce radiation exposure, and significantly improve efficacy. One of the most essential features of GEM is that it produces no artifact; this means that for the first time you can do a CT scan or MRI to see whether the embolization worked or deliver the GEM under ultrasound guidance. 

Medgadget: Is the gel intended to permanently block the target vessel? What happens to the treated vessel and gel bolus over time?

Dr. Oklu: GEM will block the vessel permanently. Because it is biocompatible, it elicits an immune reaction to the biomaterial and immune cells then biodegrade the GEM and replace it with fibrotic tissue.

Medgadget: What is the gel made of? How did you develop a material which can easily flow through a catheter, but which can form a robust bolus in situ?

Dr. Oklu: The gel consists of gelatin and nanosilicates; when pressure is applied, the gel becomes semi-solid and begins to flow, for example through the catheter. When the pressure inside the catheter stops, the gel adopts a solid state.

Medgadget: Is the gel easy to prepare and use during transcatheter procedures?

Dr. Oklu: In its pure form, the gel is easy to make; it takes a few hours. The quality assurance step is lengthy in our laboratory since we are testing it in large animals. The GEM we make has to have a certain injectable pressure using a clinical catheter, the rheological properties have to be consistent and we do a sterility test. In the future, the complexity of the gel could change as we use it as a carrier to deliver therapeutics.

Link: Obsidio homepage…

Conn Hastings

Conn Hastings received a PhD from the Royal College of Surgeons in Ireland for his work in drug delivery, investigating the potential of injectable hydrogels to deliver cells, drugs and nanoparticles in the treatment of cancer and cardiovascular diseases. After achieving his PhD and completing a year of postdoctoral research, Conn pursued a career in academic publishing, before becoming a full-time science writer and editor, combining his experience within the biomedical sciences with his passion for written communication.

Sponsored
Clarius L20 HD3 Receives Highest Image Quality Ranking Among Five Point-of-Care Ultrasound Devices

Clarius L20 HD3 Receives Highest Image Quality Ranking Among Five Point-of-Care Ultrasound Devices

Viral Vector Manufacturing in Gene Therapy and Vaccine Development

Health and Clean Air: Why Indoor Ventilation Matters

Health and Clean Air: Why Indoor Ventilation Matters

New Survey Finds Strong Consumer Preference for More Natural Hernia Repair Options

MedTech Outlook 2023 for Latin America Released

MedTech Outlook 2023 for Latin America Released

interviews & reviews
Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

Visually Guided Uterine Biopsies in Physician’s Office: Interview with Allison London Brown, CEO of LUMINELLE

Visually Guided Uterine Biopsies in Physician’s Office: Interview with Allison London Brown, CEO of LUMINELLE

AI-Powered Pain Relief: Interview with Claire Smith, VP at Nevro

AI-Powered Pain Relief: Interview with Claire Smith, VP at Nevro

MISHA Knee Shock Absorber: Interview with Anton Clifford, CEO of Moximed

MISHA Knee Shock Absorber: Interview with Anton Clifford, CEO of Moximed

Shelf-Stable Breast Milk Powder: Interview with Dr. Vansh Langer, CEO at BBy

Shelf-Stable Breast Milk Powder: Interview with Dr. Vansh Langer, CEO at BBy

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email